Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

For Breakthrough Results, Skinfuse Your Practice
  • USA - English


News provided by

Bellus Medical

Jul 28, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Skinfuse product line
Skinfuse product line

Skinfuse allows patients to leave the office with a plan that will give them peace of mind and enhanced results.

Post this

(PRWEB) July 28, 2015 -- Bellus Medical, the maker of SkinPen, has launched Skinfuse, a microneedling focused protocol to enhance the microneedling experience and add patient loyalty to the medical practice. Formulated specifically to assist in tissue remodeling post-microneedling, Skinfuse delivers essential nutrients into the skin cells to optimize the results of the procedure. Equally important is introducing the nutrients at the appropriate time post procedure. Additionally, Skinfuse omits ingredients with potential to hinder the rejuvenation process, further enhancing the microneedling results and the experience.

Dermatologists, medi spas, doctors, aestheticians and patients all agree on the value of a sound microneedling plan. Beyond the in office microneedling procedure, a comprehensive plan includes the protocol delivered by Skinfuse. The easy to follow post-microneedling system provides a consistent post-procedure protocol. Because patients are delighted with their results, they will share their experience with their friends and become loyal practice advocates.

Brian Reedy, MD Board Certified Plastic Surgeon explained, “SkinPen and Skinfuse have been a great addition to my practice. My patients have been very satisfied and it has had a significant impact on my practice’s bottom line.”

Aesthetic patients often think that a procedure stops after they leave the physician’s office. However, with procedures such as microneedling, what is done following the procedure has been observed to be as important as the procedure itself for achieving the best possible results. Along with proper diet, exercise and ample sleep, patients and clinicians should insist on using only Skinfuse post-procedure products that include ingredients essential to assist in tissue remodeling. Patients should avoid those products that may promote inflammation or delay wound repair. The goal is to give the skin what it needs to repair itself and to restore a natural balance following a microneedling procedure.

Following the rapid growth of microneedling procedures in the market, the Bellus research and development team responded to an urgent market need: the demand of patients and practice owners for a targeted post-treatment protocol. Skinfuse was designed for that singular purpose.

When asked why Bellus Medical created Skinfuse, Joe Proctor, CEO explained, “Our goal was to achieve a safe and effective answer to address the question, ‘What skincare products should I use with microneedling?’ We had seen a collection of products used post-procedure that were inconsistent. Our team is recognized as a thought leader in the medical aesthetics industry. We used our expertise to formulate this remarkable skin care protocol. Skinfuse allows patients to leave the office with a plan that will give them peace of mind and enhanced results.”

The Bellus Medical driving principles behind Skinfuse include:

Superior Product Quality
Delivering a superior product and service is first for Bellus Medical. Skinfuse is developed, produced and manufactured in the United States by a team of experts in the skincare field. The products meet the highest quality standards.

Customer Care
Bellus Medical heard from their practice owners a need for quality microneedling recovery products. The customers were asking what to do next and were demanding formulations specifically for use to support the microneedling procedure. Skinfuse was developed out of customer need.

Response to Doctors
Bellus Medical is attuned to changes, conditions and competitive information in the market. They are committed to deliver quality products to meet customers’ needs, grow practices’ business, and educate the practitioner.

Specific Development
The medical practices they engage with are considered partners, and Bellus Medical is focused on delivering a superior microneedling experience for all patients. The Skinfuse product line is a niche protocol that is not served by current anti-aging, inflammation or acne protocols.

Focus on ultimate goal of turning patients into practice advocates
It is far easier to keep a patient than to constantly find and attract new patients. There are many factors to consider, but retention reflects on practice reputation and brand. Moreover, for many practices it influences—either positively or negatively—referrals by patients and fellow professionals. Skinfuse adds an element of care, consistency and value to a microneedling procedure that drives a positive patient experience.

Aestheticians can recommend Skinfuse with confidence, and count on a predictable result. Skinfuse takes the guesswork out of ‘at home’ care for the patient and extends the quality, caring environment from the practice to the home.

ABOUT BELLUS MEDICAL

We offer solutions for medical aesthetic practices in strategic areas of growth. We are committed to providing compelling, differentiated products that enhance the patient experience and represent a significant business opportunity for our practice partners.

Foundationally, Bellus Medical is built upon three principles: customer service, technology, and education. With these principles underlying our direction, we view each of the practices we serve as strategic partnerships. We are much more than a supplier to your aesthetic practice. Bellus Medical has designed specific implementation programs to achieve significant improvement to your bottom line.

We teach your practice how to move from satisfied patients to practice advocates. Technology that is introduced into your practice is a strategic investment not only for your practice, but also for your patients. Technology is not enough to increase your bottom line. It needs to be coupled with the best training to create better patient outcomes as well as opportunities for your practice to expand. We provide nationwide training opportunities designed to ensure success with Bellus Medical products in your practice. Reach out to us today and discover the difference of a true partnership and investment in your success.

Visit us to learn more about Bellus Medical, SkinPen and Skinfuse at Bellus Medical: http://www.bellusmedical.com/

Angela McDonald, Bellus Medical, http://www.bellusmedical.com, +1 888-372-3982, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.